The “SARS-COV-2–human PPI network” constructed in this study, indicates that mTOR may be a potential key target of COVID-19, and its inhibitors may elicit curative anti-SARS-COV-2 effects (Gordon et al., 2020). The gene discussed is MTOR; the disease is COVID-19.